Comparative evaluation of amisulpride and escitalopram on Hamilton Depression Rating Scale among depression patients in a tertiary care teaching hospital in Nepal
Journal Title: International Journal of Medical Science and Public Health - Year 2015, Vol 4, Issue 5
Abstract
Background: Depression is a considerable global public health problem and is a major cause of disability and premature death. It results in poor quality of life in patients and caregivers. Objective: The present study was conducted to compare efficacy and safety of amisulpride and escitalopram, using Hamilton Depression Rating Scale (HAM-D) among depression patients in a tertiary care teaching hospital in Nepal. Material and Methods: This study was conducted in the Department of Neuropsychiatry, Nepalganj Medical College, a tertiary care teaching hospital in Nepal, for a period of 1 year. A total of 117 depression patients were randomly selected and divided into two groups. Group I (58 patients) received amisulpride 50 mg/day orally and Group II (59 patients) were given escitalopram 10 mg/day orally. The patients were followed up at 4, 8, and 15 weeks. The efficacy of the drugs was calculated by HAM-D. Adverse drug reactions were monitored at every follow-up. GraphPad Instat, version 3.0, tool was used for statistical analysis and p-value <0.05 was considered significant. Results: HAM-D score in the group receiving amisulpride at 0 and 15 weeks was 16.92 ± 0.35 and 7.87 ± 0.29 ( p < 0.0001). HAM-D score in group receiving escitalopram at 0 and 15 weeks was 17.09 ± 0.39 and 6.63 ± 0.39 ( p < 0.0001). Intergroup comparison at 15 weeks was more significant for escitalopram ( p < 0.05). Gastrointestinal disturbances, sexual disturbances, amenorrhoea lactation, agitation and insomnia were the commonly encountered adverse drug reactions. Conclusion: The present study showed both amisulpride and escitalopram were highly effective in improving the HAM-D score and in the treatment of depression. But intergroup comparison showed greater reduction in HAM-D score in patients receiving escitalopram
Authors and Affiliations
Vijay Kaul, Shaktibala Dutta, Mirza Atif Beg, Nand Kishore Singh, Shalu Bawa, Mohammad Anjoom, Srihari Dutta
Keywords
Related Articles
- EP ID EP143253
- DOI 10.5455/ijmsph.2015.23012015132
- Views 77
- Downloads 0
Dyslipidemia in hypothyroid subjects with Hashimoto’s thyroiditis
Background: The relationship between hypothyroidism and dyslipidemia is poorly understood. Objective: We aimed to describe the relationship between serum thyroid-stimulating hormone (TSH) and fasting lipid profil...
Prevalence of Helicobacter pylori infection in gastric and duodenal lesions as diagnosed by endoscopic biopsy
Background: Helicobacter pylori is associated with various diseases, mainly, many benign, premalignant, and malignant lesions of the digestive system. Colonization of stomach by H. pylori and chronic active gast...
Evaluation of blood donor deferral causes: a tertiary-care center-based study
Background: Donor selection is necessary in addition to the screenings of blood bags for infectious diseases. Deferrals lead to loss of precious blood/components available for transfusion. For preventing this, we sho...
Comparative evaluation of surgical modalities in cases with obstructive sleep apnea syndrome
Background: Sleep apnea is divided into three main types: central sleep apnea syndrome (CSAS), obstructive sleep apnea syndrome (OSAS), and mixed sleep apnea syndrome (MSAS). OSAS is responsible for 80% of cases o...
Prevalence and awareness of reproductive tract infections among women in select underprivileged areas of Bangalore city
Background: Reproductive tract infections (RTIs) and sexually transmitted infections (STIs) present a huge burden of disease and adversely impact reproductive health of people. They are more common in developing coun...